Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours

Archives of Medical Science

Volumn 8, Issue 5, 2012, Pages 848-853

  Mielczarek Palacz, Aleksandra ^a   Kondera Anasz, Zdzisława ^a   Sikora, Justyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Ovarian tumours; Soluble receptor of tumour necrosis factor; Tumour necrosis factor

Indexed keywords

TUMOR MARKER; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTADENOMA; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CYST; OVARY TUMOR; PROTEIN BLOOD LEVEL;

EID: 84869801980     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.31384     Document Type: Article

References (30)

1. Kwong J, Chan FL, Wong KK, et al. Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia 2009; 11: 529-41.
2. Fulda S. Cell death in hematological tumors. Apoptosis 2009; 14: 409-23.
3. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 2008; 29: 1275-88.
4. So T, Lee SW, Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol 2006; 83: 1-11.
5. Ihnatko R, Kubes M. TNF signaling: early events and phosphorylation. Gen Physiol Biophys 2007; 26: 159-67.
6. Popivanova BK, Kitamura K, Wu Y, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008; 118: 560-70.
7. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-56.
8. Shen HM, Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 2006; 20: 1589-98.
9. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009; 9: 361-71.
10. Rzymski P. Tumor necrosis fFactor alpha receptors p55 and p75 and ovarian cancer - state-of-the-art research and clinical implications. Arch Med Sci 2005; 1: 3-7.
11. Dobrzycka B, Terlikowski SJ, Kowalczuk O, Kinalski M. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer. Eur Cytokine Netw 2009; 20: 131-4.
12. Yigit R, Figdor CG, Zusterzeel PL, Pots JM, Torensma R, Massuger LF. Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer. Eur J Cancer 2011; 47: 1883-9.
13. Gadducci A, Ferdeghini M, Castellani C, et al. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. Gynecol Oncol 1995; 58: 184-8.
14. Maccio A, Lai P, Santona MC, Pagliara L, Melis GB, Mantovani G. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer. Gynecol Oncol 1998; 69: 248-52.
15. Kutteh WH, Kutteh CC. Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms. Am J Obstet Gynecol 1992; 167: 1864-9.
16. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 1993; 91: 2194-206.
17. Fukuda T, Yamaguchi T, Yamaki T, Suzuki T. Ovarian fibrosarcoma producing multiple cytokines. Pathol Int 2001; 51: 739-43.
18. Nowak M, Glowacka E, Szpakowski M, et al. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors. Neuro Endocrinol Lett 2010; 31: 375-83.
19. Gadducci A, Tana R, Cosio S, Genazzani AR. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. Crit Rev Oncol Hematol 2008; 66: 10-20.
20. Kulbe H, Thompson R, Wilson JL, et al. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 2007; 67: 585-92.
21. Grosen EA, Granger GA, Gatanaga M, et al. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. Gynecol Oncol 1993; 50: 68-77.
22. Rzymski P, Opala T, Wilczak M, Woźniak J, Sajdak S. Serum tumor necrosis factor alpha receptors p55/p75 ratio and ovarian cancer detection. Int J Gynaecol Obstet 2005; 88: 292-8.
23. Opala T, Rzymski P, Wilczak M, Woźniak J. Evaluation of soluble tumour necrosis factor alpha receptors p55 and p75 in ovarian cancer patients. Eur J Gynaecol Oncol 2005; 26: 43-6.
24. Gatanaga M, Grosen EA, Burger RA, Granger GA, Gatanaga T. Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitro. Lymphokine Cytokine Res 1993; 12: 249-53.
25. Burger RA, Darcy KM, DiSaia PJ, et al. Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study. Cancer 2004; 101: 106-15.
26. Szlosarek PW, Grimshaw MJ, Wilbanks GD, et al. Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer. Int J Cancer 2007; 121: 6-11.
27. Yigit R, Massuger LF, Zusterzeel PL, Pots J, Figdor CG, Torensma R. Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor. Int J Gynecol Cancer 2011; 21: 1241-7.
28. Langkopf F, Atzpodien J. Soluble tumour necrosis factor receptors as prognostic factors in cancer patients. Lancet 1994; 344: 57-8.
29. Buks J, Wilczak M, Rzymski P, Opala T. Do soluble p55 and p75 TNF-alpha receptor concentrations play a role in women with primary sterility? Arch Med Sci 2010; 6: 264-9.
30. Tao Y, Zhang Q, Huang W, Zhu H, Zhang D, Luo W. The peritoneal leptin, MCP-1 and TNF-alpha in the pathogenesis of endometriosis-associated infertility. Am J Reprod Immunol 2011; 65: 403-6.